Therapeutic Drug Monitoring of BRAF-mutated Advanced Melanoma

Clinical trial NCT03416933 · COMPLETED

Trial details

NCT number: NCT03416933
Sponsor: Institut de Cancérologie de Lorraine
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2018-04-27
Primary completion: 2022-06-17
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.